NCT02905994 2018-05-04
Volasertib Combined With Induction Chemotherapy in Acute Myeloid Leukemia
Massachusetts General Hospital
Phase 1 Withdrawn
Clinical Trials
4 trialsNCT02198482 2018-02-28
Trial of Intensive Chemotherapy With or Without Volasertib in Patients With Newly Diagnosed High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
University of Ulm
Phase 2 Terminated
NCT02527174 2017-04-05
VIAC
University of Alberta
Phase 1 Withdrawn
NCT02861040 2016-12-15
Volasertib and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Northwestern University
Phase 1 Withdrawn